Alpha-1-Antitrypsin is a glycoprotein synthesised in hepatocytes and is quantitatively the most important proteinase inhibitor (Pi) in serum and plasma. It specifically inactivates serine proteases (eg. Trypsin, chymotrypsin, collagenase, leucocyte elastase, plasmin and thrombin) with which it reversibly forms an enzyme-indicator complex.
Acute hereditary alpha-1-Antitrypsin deficiency is suspected in cases of neonatal hepatitis accompanied by progressive liver cirrhosis in early childhood. It is also suspected when severe pulmonary emphysema occurs in adults due to the prevalence of leucocyte elastase, which can lead to unrestrained proteolytic degradation of the pulmonary parenchymal cells.
Genetic variants of A1AT are characterised by their different electrophoretic mobilties i.e. M, S or Z. Z and S variants have decreased synthesis of A1AT. S forms produce 60-80% of normal and Z produces only 15% of normal. Normal range is age related.
Analysis is carried out at the Heartlands Hospital site only. Samples sent to the QEHB laboratory will be forwarded onto the Heartlands laboratory for analysis.
None
No significant interference from haemolysis, icterus, or lipaemia. Elevated oestrogen levels (oral contraceptives, 3rd trimester of pregnancy) give rise to false positive results
Adult range 1.1 - 2.1 g/L.
Age related ranges are available by contacting the Immunology department (Heartlands Hospital).
UK NEQAS for Specific Proteins scheme
Copyright UHB Pathology 2018
Protection of Personal Information – Clinical Laboratory Services comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
University Hospitals Birmingham medical laboratories at Queen Elizabeth Hospital, Heartlands Hospital, Good Hope Hospital and Solihull Hospital are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/
Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further test information, please visit the test database: http://qehbpathology.uk/test-database
For further information contact Louise Fallon, Quality Manager, 0121 371 5962